|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 211/46 | (2006.01) |
| C07D 211/46 | (2013.01) | ||
| A61P 3/00 | (2006.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 25/16 | (2006.01) | ||
| A61P 25/16 | (2018.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 9/10 | (2018.01) | ||
| A61K 31/445 | (2006.01) |
| (11) | Patento numeris | 4114826 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 21798287.5 |
| Europos patento paraiškos padavimo data | 2021-10-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2023-01-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-08-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2021/077100 |
| Data | 2021-10-01 |
| (87) | Numeris | WO 2022/069709 |
| Data | 2022-04-07 |
| (30) | Numeris | Data | Šalis |
| 20199934 | 2020-10-02 | EP |
| (72) |
HETT, Robert , NL
BLATTER, Fritz , NL
ROBIN, Jennifer , NL
LANDSKRONER, Kyle , CH
|
| (73) |
Azafaros B.V. ,
J.H. Oortweg 21, 2333 CH Leiden,
NL
|
| (54) | CRYSTALLINE FORMS OF A PHARMACEUTICAL COMPOUND |
| CRYSTALLINE FORMS OF A PHARMACEUTICAL COMPOUND |